Healthcare Triangle Reports 627% Increase in Gross Profit and 166% Increase in Revenue for Q1 2026

Healthcare Triangle (Nasdaq:HCTI) reported strong Q1 2026 results, driven by its January acquisition of Teyame 360 and Datono.

Rhea-AI Summary

Healthcare Triangle (Nasdaq:HCTI) reported strong Q1 2026 results, driven by its January acquisition of Teyame 360 and Datono.

Revenue rose 166% year-over-year to $9.9M, while gross profit increased 627% to $2.4M and gross margin expanded from 9% to 24%.

The new Customer Engagement Services segment, created from the acquired businesses, delivered $6.9M revenue (about 70% of total), $2.0M gross profit and roughly 29% segment margin, offsetting modest declines in legacy Software Services and Managed Services. Management expects further gross margin improvement as integration and cross-selling progress.

Positive

• Q1 2026 revenue up 166% year-over-year to $9.9M
• Gross profit up 627% year-over-year to $2.4M
• Consolidated gross margin improved 15 points from 9% to 24%
• Acquired businesses contributed $6.9M revenue, about 70% of Q1 2026 total
• Customer Engagement Services segment generated $2.0M gross profit at ~29% margin

Negative

• Legacy Software Services and Managed Services segments experienced modest revenue declines

Argus May 14 session

+4.11% close to close Open Argus

Details

News Market Reaction – HCTI

On May 14, the day this news came out, HCTI closed 4.11% above the previous close.

Data tracked by StockTitan Argus for the May 14 session.

Market Context

This announcement highlights a transformative Q1 2026, with revenue reaching $9.9M (up 166%) and gro...

Analysis

This announcement highlights a transformative Q1 2026, with revenue reaching $9.9M (up 166%) and gross profit $2.4M (up 627%). The Teyame and Datono acquisition contributed $6.9M of revenue and $2.0M gross profit at a 29% margin, lifting consolidated gross margin from 9% to 24%. Recent filings note expanded assets but also higher losses and active capital markets usage, so ongoing profitability, cash flows, and potential equity issuance remain key metrics to watch.

Key Figures

Q1 2026 Revenue: $9.9M Q1 2025 Revenue: $3.7M Revenue Growth: 166% +5 more

Q1 2026 Revenue

$9.9M

Total revenue Q1 2026

Q1 2025 Revenue

$3.7M

Total revenue Q1 2025 baseline

Revenue Growth

166%

Year-over-year revenue increase Q1 2026 vs Q1 2025

Q1 2026 Gross Profit

$2.4M

Consolidated gross profit in Q1 2026

Q1 2025 Gross Profit

$0.3M

Consolidated gross profit in Q1 2025

Gross Profit Growth

627%

Year-over-year gross profit increase Q1 2026 vs Q1 2025

Teyame & Datono Revenue

$6.9M

Q1 2026 revenue contribution from acquired subsidiaries

Customer Engagement Gross Margin

29%

Q1 2026 gross margin of new Customer Engagement Services segment

Historical Context

5 past events · Latest: Apr 23

5 events

1. Apr 23

   AI platform launch

   24h Move

   -9.3%

   Launch of ZoraNex AI self-care therapy app targeting $450B mental health market.

2. Apr 08

   Africa client wins

   24h Move

   -3.3%

   New healthcare clients across multiple African countries and LIMS partnership in Ethiopia.

3. Mar 25

   Agentic AI rollout

   24h Move

   -4.8%

   Deployment of Agentic AI in Teyame.AI platform targeting U.S. and LatAm markets.

4. Mar 11

   Share repurchase plan

   24h Move

   -4.3%

   Board approval of a $2,000,000 share repurchase program funded from available liquidity.

5. Feb 27

   Dubai expansion

   24h Move

   -17.5%

   QuantumNexis launch in Dubai to drive digital health and AI hospital solutions in GCC.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Recent Acquisitions powers the Revenue Growth and Gross Profit

PLEASANTON, Calif., May 14, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today reported financial results for the first quarter ended March 31, 2026. The Company's results reflect the transformative impact of its January 2026 acquisition of Teyame 360 S.L. ("Teyame") and Datono Mediacion S.L. ("Datono"), which together contributed a new and highly accretive revenue stream that significantly scaled the Company's top line, improved gross profit, and expanded margins in the quarter.

Q1 2026 Financial Highlights

	Q1 2026	Q1 2025	Change
Total Revenue	$9.9M	$3.7M	+166 %
Gross Profit	$2.4M	$0.3M	+627 %
Gross Margin	24 %	9 %	+15% pts

The Teyame and Datono Acquisition: A Transformative Quarter

The January 22, 2026 signing of HCTI's purchase agreement for the acquisitions of Teyame and Datono through the Company's wholly owned subsidiary, Teyame AI Holdings Inc., was the defining event of the first quarter and is the primary driver of the Company's strong financial performance. The acquired companies, which operate as an integrated AI-powered omnichannel customer experience, marketing, and financial and insurance distribution platform, contributed $6.9 million in revenue in their first quarter of consolidation — representing approximately 70% of HCTI's total Q1 2026 revenue.

This contribution established a new Customer Engagement Services segment that generated $2.0 million in segment gross profit at a gross margin of approximately 29%, meaningfully above the Company's historical margin profile. The addition of Teyame and Datono was the single largest driver of the Company's overall gross margin expansion from 9% in Q1 2025 to 24% in Q1 2026.

Revenue impact: Total consolidated revenue grew by $6.2 million year-over-year to $9.9 million, with the Customer Engagement Services segment — entirely attributable to the Teyame and Datono acquisition — accounting for the full incremental growth and more than offsetting modest declines in the legacy Software Services and Managed Services segments.

Gross profit impact: Consolidated gross profit increased by approximately $2.1 million, from $0.3 million in Q1 2025 to $2.4 million in Q1 2026. The Teyame and Datono businesses contributed $2.0 million of that improvement, reflecting their strong unit economics and value-added service model.

Gross margin impact: The addition of Teyame and Datono's higher-margin revenue mix drove a 15-percentage-point expansion in consolidated gross margin, from 9% to 24%. Management expects gross margins to continue to improve as the integration matures and cross-selling initiatives gain traction.

About Teyame and Datono

Teyame 360 S.L. is an AI-powered customer engagement company that combines artificial intelligence, telemarketing, and contact center operations to support customer acquisition, retention, and service for enterprises in financial services, insurance, and healthcare. Datono Mediacion S.L. complements Teyame as an insurance brokerage entity, facilitating the marketing and sales of insurance products. Together, the companies deliver a vertically integrated, full-cycle customer lifecycle solution — from AI-driven lead generation and customer acquisition through to conversion, policy distribution, and ongoing servicing.

David Ayanoglou, Chief Financial Officer of Healthcare Triangle, commented:

"The acquisition of Teyame and Datono has had an immediate and material positive impact on our financial results. In their very first quarter as part of Healthcare Triangle, these businesses contributed nearly $6.9 million in revenue and $2.0 million in gross profit, and were the primary driver of our gross margin more than doubling year-over-year. This is precisely the kind of transformative, margin-accretive growth we envisioned when we pursued this acquisition. We are excited about what this platform means for Healthcare Triangle's future — not only as a significant revenue contributor in its own right, but as an AI-driven capability that we believe will enhance our broader healthcare technology offerings."

About Healthcare Triangle

Healthcare Triangle, Inc. based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. We support healthcare organizations including hospitals and health systems, payers, and pharma/life sciences organizations in their effort to improve health outcomes through better utilization of the data and information technologies that they rely on. Healthcare Triangle achieves HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™. HITRUST Risk-based, 2-year (r2) Certified status demonstrates to our clients the highest standards for data protection and information security. Healthcare Triangle enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and competitive threats. The highly regulated healthcare and life sciences industries rely on Healthcare Triangle for expertise in digital transformation encompassing the cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical & business performance optimization.

Forward-Looking Statements and Safe Harbor Notice

All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995), and include, among others, statements regarding the consummation of the private placement, satisfaction of the customary closing conditions of the private placement and the use of the proceeds therefrom. Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties, and assumptions, including market and other conditions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors out lined in the company's annual report on form 10-K for the year ended December 31, 2025, on file with the Securities Exchange Commission (the "SEC") and in previous filings, subsequent filings and future periodic reports filed with the SEC. All the company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.

Investors:
1-800-617-9550
ir@healthcaretriangle.com

Financial tables and full results are available in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission.

View original content:https://www.prnewswire.com/news-releases/healthcare-triangle-reports-627-increase-in-gross-profit-and-166-increase-in-revenue-for-q1-2026-302771806.html

SOURCE Healthcare Triangle, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How did Healthcare Triangle (Nasdaq:HCTI) perform in Q1 2026?

Healthcare Triangle reported sharply higher Q1 2026 results, with strong gains in revenue and profitability. According to Healthcare Triangle, revenue reached $9.9M, up 166% year-over-year, while gross profit rose to $2.4M, a 627% increase, and gross margin improved from 9% to 24%.

What drove Healthcare Triangle's 166% revenue growth in Q1 2026 (HCTI)?

The 166% revenue growth in Q1 2026 was primarily driven by acquisitions. According to Healthcare Triangle, the Teyame and Datono businesses contributed $6.9M of revenue in their first consolidated quarter, representing about 70% of total Q1 2026 revenue and offsetting modest declines in legacy segments.

How did the Teyame and Datono acquisition affect HCTI's gross profit and margins in Q1 2026?

The Teyame and Datono acquisition significantly boosted gross profit and margins. According to Healthcare Triangle, the acquired businesses generated $2.0M segment gross profit at about 29% margin and drove consolidated gross profit from $0.3M to $2.4M, lifting gross margin from 9% to 24%.

What is Healthcare Triangle's new Customer Engagement Services segment (HCTI)?

The Customer Engagement Services segment is built around Teyame and Datono's AI-powered omnichannel platform. According to Healthcare Triangle, this new segment contributed $6.9M of Q1 2026 revenue, about 70% of total, and delivered $2.0M gross profit at an approximate 29% gross margin in its first quarter of consolidation.

Did Healthcare Triangle's legacy businesses grow in Q1 2026 (HCTI stock)?

Healthcare Triangle reported modest revenue declines in its legacy businesses during Q1 2026. According to Healthcare Triangle, the Software Services and Managed Services segments saw slight decreases, while the newly acquired Customer Engagement Services segment fully accounted for the $6.2M year-over-year revenue increase to $9.9M.

What is Healthcare Triangle's outlook for gross margins after Q1 2026?

Management expects gross margins to continue improving beyond Q1 2026. According to Healthcare Triangle, the higher-margin revenue mix from Teyame and Datono drove a 15-point gross margin increase to 24%, and management anticipates further gains as integration matures and cross-selling initiatives expand.